|
Envision ALR Announces Rapid Screening for Swine Flu and Other Pathogens Using Novel Nanotechnology Based Plastic Electronics
High throughput & portable nanotechnology based screening for Swine Flu and other pandemics
LONDON - April 28 2009 -- Envision ALR, an emerging technology investment & operating company announced today that it is commercialising a new form of nanotechnology based infectious disease detection system with the capability to distinguish between different flu strains within seconds. The technology has already been shown to be effective in lab tests and the company is now accelerating the commercialisation program.
Envision ALR CEO Wassim Mourtada explained from Abu Dhabi "Global pandemics, or even the fear of them have a severe economic impact. With current disease identification technologies requiring blood samples to be shipped to a laboratory for testing, distinguishing between pandemic strains and common ones can take up to twenty-four hours. Our technology has the potential to reduce this to under a minute, requires either a pin prick of blood or a salvia sample and will deliver the result of the diagnoses on the spot."
The technology is based on printed electronics, making use of the unique properties of a number of nanoparticle based inks and is rapid, accurate, and the hand held device is easily portable for use in doctors surgeries, hospitals or airports. The system works for both bacterial and viral pathogens, and tests performed by the Naval Research Lab in Washington DC using Staphylococcus Enterotoxin B showed a two order of magnitude improvement over the current 'Lab Golden Standard' test.
President of Nanotechnologies at Envision ALR, Tim Harper commented, "We originally made this acquisition as a platform technology to enable a wide range of low cost high speed point of care applications, from allergy testing to infectious disease control. Given the concern over the current potential Swine Flu pandemic we have decided to accelerate our development and will have devices in the field by the end of the year. These will be capable of rapidly distinguishing between pathogens, reducing false alarms and making better use of healthcare facilities, and the use of printed electronics means that large numbers of devices can be quickly produced to respond to any new emerging pathogen."
About Envision ALR
Envision ALR is a diversified operating company, developing products for healthcare, energy, water, chemicals and materials based on nanotechnology, regenerative medicine and industrial biotechnology. For more information visit www.envisionalr.com
Contacts:
Envision ALR
Tim Harper
+44-7894-708989
tim.harper@envisionalr.com
Published at Investorideas.com and nanotech investor portal NanotechnologyInvestment.com
Research Nanotech stocks at the global stock directory - click here
Investorideas.com Membership – Access full Biotech Stocks Directory, water stocks and more...
With markets and investor sentiment changing daily - it is more important than ever to stay on top of key trends! Gain Exclusive Insight on Leading Sectors, Global Trends, and Insider Trading Ideas, News, Articles and Investor Ideas Members only Restricted Content including the complete renewable energy stocks directory, water stocks, biotech and defense stocks directory, as well as the Insiders Corner by Michael Brush.
Become an InvestorIdeas.com - Learn more: http://www.investorideas.com/membership/
Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
|
